Synthesis of novel aza analogues of 2-substituted-2,3-dihydro-1,4-benzodioxins as potential new scaffolds for drug discovery

Tetrahedron Letters

Volumn 44, Issue 11, 2003, Pages 2275-2277

  Matesanz, Encarna ^a   Alcázar, Jesús ^a   Andrés, J Ignacio ^a   Bartolomé, Jose M ^a   De Bruyn, Marcel ^b   Fernández, Javier ^a   Van Emelen, Kristof ^b  

^a Jarama S/n 45007 Toledo Spain   (Spain)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

1,4 benzodioxin; 1,4 pyridodioxin; Heterocycles; Novel scaffolds; Pyridine

Indexed keywords

8 [4 (1,4 BENZODIOXAN 2 YLMETHYLAMINO)BUTYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; AROMATIC COMPOUND; CALCIUM ANTAGONIST; DIOXIN; METHYL GROUP;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG STRUCTURE; DRUG SYNTHESIS; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; OXYGENATION; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0037430580     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(03)00281-8     Document Type: Article

References (21)

1. For recent reports involving 2,3-dihydro-1,4-benzodioxin derivatives, see: (a) Czompa, A.; Dinya, Z.; Antus, S.; Varga, Z. Arch. Pharm. 2000, 333, 175-180;
2. (b) Gu, W. X.; Jing, X. B.; Pan, X. F.; Chan, A. S. C.; Yang, T. K. Tetrahedron Lett. 2000, 41, 6079-6082;
3. (c) Ward, R. S. Nat. Prod. Rep. 1999, 16, 75-96;
4. (d) Bolognesi, M. L.; Budriesi, R.; Cavalli, A.; Chiarini, A.; Gotti, R.; Leonardi, A.; Minarini, A.; Poggesi, E.; Recanatini, M.; Rosini, M.; Tumiatti, V.; Melchiorre, C. J. Med. Chem. 1999, 42, 4214-4224;
5. (e) Guillaumet, G. In Comprehensive Heterocyclic Chemistry II, 1st ed.; Katrizky, A. R.; Rees, C. W.; Scriven, E. F. V., Eds.; Pergamon: Oxford, 1996; Vol. 6, pp. 447-463.
6. Wermuth C.G. Wermuth C.G. The Practice of Medicinal Chemistry. 1996;203-238 Academic Press, London.
7. Benarab A., Guillaumet G. Heterocycles. 36:1993;2327-2333.
8. Comoy C., Benarab A., Monteil A., Leinot M., Massingham R., Guillaumet G. Med. Chem. Res. 1996;392-399.
9. Sánchez I., Pujol M.D., Guillaumet G., Massingham R., Monteil A., Dureng G., Winslow E. Sci. Pharm. 68:2000;159-164.
10. Soukri M., Lazar S., Akssira M., Guillaumet G. Org. Lett. 2:2000;1557-1560.
11. Benarab A., Commoy C., Guillaumet G. Heterocycles. 38:1994;1641-1650.
12. Holladay M.W., Bai H., Yihong L., Nan-Horng D., Jerome F., Ryther K.B., Wasicak J.T., Kincaid J.F., He Y., Hettinger A.-M., Huang P., Anderson D.J., Bannon A.W., Buckley M.J., Campbell J.E., Donnelly-Roberts D.L., Gunter K.L., Kim D.J.B., Kuntzweiler T.A., Sullivan J.P., Decker M.W., Arneric S.P. Bioorg. Med. Chem. Lett. 8:1998;2797-2802.
13. When DMF was used as solvent the allyloxygroup of 11 underwent spontaneous isomerization to the corresponding enol-ether.
14. 3 at reflux or NaH in DMF at room temperature, a mixture of two compounds was obtained. In both cases the desired product was the minor fraction while the structure of the major fraction could not be determined.
15. +: 230.
16. Mitsunobu O. Synthesis. 1981;1-28.
17. Park M.H., Takeda R., Nakanishi K. Tetrahedron Lett. 28:1987;3823-3824.
18. +: 230.
19. When the reaction was carried out on DMF or DMSO as solvents the yield of the process dramatically decreased.
20. Kress T.J. J. Org. Chem. 50:1985;3073-3076.
21. +: 231.